Malaria in first trimester pregnancy — DTM&H MCQ

Correct answer: D — Oral quinine plus clindamycin for 7 days

The correct answer is D, oral quinine plus clindamycin for 7 days. UK malaria treatment guidelines specify that uncomplicated falciparum malaria in the first trimester should usually be treated with quinine and clindamycin, with specialist advice sought given the higher stakes of first-trimester therapy. Quinine has the longest track record of safety data in early pregnancy among antimalarials, and clindamycin is substituted for doxycycline (which is contraindicated throughout pregnancy) to provide a partner drug that limits quinine resistance and shortens the effective course. Artemisinin combination therapies are reserved for the second and third trimesters in UK guidance because first-trimester safety data remain comparatively limited. Why the other options are wrong: A, Artemether-lumefantrine for 3 days: this ACT is the guideline-recommended first-line treatment for uncomplicated falciparum malaria in the second and third trimesters, not the first, due to less first-trimester embryotoxicity data. C, Artesunate monotherapy for 7 days: monotherapy with an artemisinin derivative is never recommended for uncomplicated malaria in any patient group because it risks selecting for resistant parasites; artesunate is used only in combination or intravenously for severe disease. D, Sulfadoxine-pyrimethamine single dose: this is used for intermittent preventive treatment in pregnancy in high-transmission settings, not for treating an acute confirmed episode of uncomplicated falciparum malaria in the UK. E, Atovaquone-proguanil for 3 days: this combination lacks sufficient safety data in human pregnancy, particularly in the first trimester, so it is avoided until better evidence exists. Key point: In the first trimester, quinine plus clindamycin for 7 days is preferred over ACTs because it has the most established first-trimester safety profile, with specialist input advised.

Reference: UK Malaria Treatment Guidelines 2016 (PHE/UKHSA-endorsed, Journal of Infection), Lalloo DG et al., Treatment of uncomplicated falciparum malaria in pregnancy: https://www.journalofinfection.com/article/S0163-4453(16)00047-5/fulltext